We deliver GMP-aligned, capacity-scalable engineering solutions tailored for full-spectrum veterinary vaccine manufacturing facilities, covering livestock, poultry and companion animal vaccine production. Adaptable for greenfield new-build campuses and brownfield facility retrofitting, expansion and upgrading, our integrated services cover master site planning, biosafety-graded cleanroom design, process equipment layout optimization, dedicated utility system engineering and full lifecycle validation enablement. Catering for inactivated vaccines, live attenuated vaccines, subunit vaccines and vector vaccines, our scalable engineering framework resolves core industry pain points including multi-product cross-contamination risks, unstable batch consistency and rigid capacity constraints, building inspection-ready manufacturing infrastructure for clinical trial progression, factory certification and large-scale commercial vaccine supply.
Our scalable plant engineering adheres to the core philosophy of hierarchical biosafety containment, flexible multi-campaign compatibility, modular expandable architecture and cost-effective operational stability. We deploy risk-based zoning and directional pressure cascade systems to isolate different vaccine strains and production workflows, fundamentally preventing cross-product carryover and pathogen aerosol diffusion. Standardized modular process skid interfaces and reserved expansion space support phased capacity upgrade and new product line insertion without large-scale civil reconstruction. Optimized personnel, material and waste unidirectional flow designs simplify frequent campaign switching while sustaining long-term GMP compliance and production efficiency.
All engineering design criteria, construction specifications and system configurations fully comply with international veterinary biologic GMP standards, OIE biosafety guidelines, FDA, EMA and PIC/S regulatory requirements. We implement strict bioburden control, live pathogen containment and biosafety waste inactivation engineering mechanisms to meet stringent veterinary vaccine production norms. Equipped with 21 CFR Part 11 compliant environmental monitoring and data traceability systems, the entire facility achieves full batch record traceability and audit resilience, supporting domestic and international factory inspections as well as global product registration and market access.
We provide end-to-end integrated engineering services covering pre-project feasibility analysis, conceptual and detailed facility design, on-site construction supervision, equipment integration, commissioning and complete qualification documentation delivery. Our flexible scalable execution model effectively balances initial investment cost and long-term production expansion demands, eliminating redundant construction and design rework. With standardized, safe and highly expandable plant infrastructure, clients gain agile manufacturing capabilities to adapt to dynamic veterinary vaccine market demands and achieve sustainable commercial competitiveness.
